Status:
TERMINATED
BELIEVE Study: Nesiritide and Post Myocardial Infarction Left Ventricular Modeling
Lead Sponsor:
Mayo Clinic
Conditions:
Myocardial Infarction
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
This study is being done to determine the effects (good and bad) of intravenous infusion of a human brain natriuretic peptide (BNP), Natrecor (nesiritide), a hormone produced by the heart in persons w...
Detailed Description
During the 72 hours of intravenous (IV) nesiritide infusion, if the systolic blood pressure decreases to less than 90 mmHg for 5 minutes, the coronary care unit (CCU) sx will be notified and if the sy...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients with acute ST elevation myocardial infarction of at least \> 2mV ST elevation in two or more anterior precordial leads, with successful revascularization (Thrombolysis in Myocardial Infarction \[TIMI\] grade 3 flow) of the lesion within 24 hours of chest pain as documented by coronary angiogram.
Exclusion
Key Trial Info
Start Date :
August 1 2002
Trial Type :
INTERVENTIONAL
End Date :
January 1 2006
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00252213
Start Date
August 1 2002
End Date
January 1 2006
Last Update
December 11 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905